ArticleCureus2026
Comparison of Esophageal Dose Parameters in Breast Cancer Radiotherapy With and Without Esophageal Contouring.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context This study investigates the effect of esophageal delineation on dose-volume parameters during breast cancer radiotherapy (RT), aiming to optimize treatment planning and reduce the risk of acute esophageal toxicity. Methods A retrospective study was conducted on radiotherapy plans from 100 patients with breast cancer (mean age: 45 years) who received three-dimensional conformal radiotherapy (3DCRT) targeting the chest wall and supraclavicular fossa (SCF). All patients were treated with a hypofractionated schedule of 40 Gy in 15 fractions. Initially, esophageal contouring was excluded. In a secondary phase, the esophagus was delineated as an organ at risk (OAR), and the plans were revised accordingly. Dosimetric comparisons included maximum (D
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.